ARRY

Array Biopharma Inc
ARRY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 315 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$943M
2
-$890M
3
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
101
–
102
–
103
–
104
–
105
–
106
–
107
–
108
–
109
–
110
–
111
–
112
–
113
–
114
–
115
–
116
–
117
–
118
–
119
–
120
–
121
–
122
–
123
–
124
–
125
–
3 4
5
6 7